Abstract
To extend our previous studies concerning the enantioseparation of 4C-substituted pyrrolidin-2-one derivatives on polysaccharide-based chiral stationary phases with ethanol/n-hexane mobile phases, two commercially available immobilized chiral stationary phases [amylose derivatized with (S)-α-methylbenzylcarbamate, and cellulose derivatized with 3,5-dichlorophenylcarbamate] were studied. Also, efforts to use macrocyclic glycopeptide (vancomycin, ristocetin A, teicoplanin, and teicoplanin aglycone) chiral stationary phases under normal-phase mode for enantioseparations of 4C-substituted pyrrolidin-2-one derivatives were made. It was established that both polysaccharide chiral stationary phases show high chiral recognition ability: 12 enantiomeric pairs on chiral selector cellulose tris (3,5-dichlorophenylcarbamate) and 11 enantiomeric pairs on chiral selector amylose tris [(S)-α-methylbenzylcarbamate] out of 15 enantiomeric pairs studied, separated with Rs ≥ 2. The results showed that the nature of the analyzed compounds plays an important role in chiral discrimination, especially in relation to CSPs based on macrocyclic glycopeptides: 4-aryl-pyrrolidin-2-ones could be resolved with Rs ≥ 2 on teicoplanin or teicoplanin aglycone chiral selectors, teicoplanin aglycone phase was able also to separate enantiomers of 4-aryl-substituted acetate derivatives, whereas 4-aryl-substituted acetamide derivatives only could be resolved on vancomycin phase.
Graphical abstract
Avoid common mistakes on your manuscript.
Introduction
Since the discovery of piracetam its structural analogs based on pyrrolidin-2-one pharmacophore have aroused a great interest, and the structural modification of substituents in the 2-pyrrolidone ring remains an active research field of medicinal chemistry [1, 2]. Introduction of a substituent into the heterocycle creates a chiral center (the compound will exist as two enantiomers), however, pharmacological activity is normally associated with single enantiomer [3]. Thus, it is necessary to search for separation methods for the enantioresolution of chiral derivatives of 4C-substituted pyrrolidin-2-ones.
It is known that for the separation of enantiomers the use of chiral stationary phases (CSPs) has become the most popular tool for determination of the enantiomeric purity of different chiral organic compounds [4]. Due to the complexity and lack of predictability in chiral separations, column screening remains the gold standard to initiate chiral method development for active pharmaceutical ingredients and synthetic intermediates [5]. Phases based on the phenylcarbamates or benzoates of polysaccharides are the most dominant and widely used CSPs [6, 7]. Furthermore, our previous studies have shown that phenylcarbamates of amylose as chiral selectors, together with mobile phases consisting of ethanol and n-hexane mixtures, are the most effective for separation of racemic 4C-substituted pyrrolidine-2-one derivatives [8, 9]. The best result (Rs ≥ 2 for 80% or 12 of 15 enantiomeric pairs) was observed on immobilized amylose tris (3-chloro-4-methylphenylcarbamate) and coated amylose tris (5-chloro-2-methylphenylcarbamate) CSPs [9].
To extend this research, comparative HPLC study on different type chiral stationary phases was performed. First of all, two commercially available immobilized polysaccharide-based Chiralpak IC (IC) and Chiralpak IH (IH) columns were tested. The high enantiorecognition ability of cellulose tris (3,5-dichlorophenylcarbamate) chiral selector (CS) is well known [10, 11]. Therefore, an immobilized IC column was chosen for our study, even though our previous studies showed weaker chiral discrimination on the coated cellulose-based phases [11]. The IH phase is one of the latest additions to the family of immobilized CSPs and represents a significant improvement over the coated Chiralpak AS stationary phase, offering wider solvent versatility and robustness [12]. IH was chosen due to its amylose backbone (found superior in our previous studies), combined with a different type of ligand—(S)-α-methylbenzylcarbamate (in contrary to phenylcarbamates), giving hope, that this CS could provide specific chiral recognition for racemic 4C-substituted pyrrolidine-2-one derivatives.
In addition to polysaccharides, another group of successful chiral selectors in use today are known to be macrocyclic glycopeptides, commercially available under the tradename Chirobiotic. One of the unique characteristics of macrocyclic glycopeptide CSPs is the complementary effect among these CSPs [13]. Macrocyclic glycopeptide CSPs are multi-modal, meaning a variety of mobile phase types can be used to initiate selectivity. Moreover, these phases can be switched from one mobile phase system to another without any deleterious effect. Typically, the highest success rate in enantioseparations of pharmaceutical compounds is achieved under both reversed-phase and polar ionic mode. However, elution under polar organic and normal-phase conditions also occurs on macrocyclic glycopeptide CSPs [14]. Normal-phase elution on macrocyclic glycopeptide CSPs is used mainly for neutral compounds [13]. For example, the best separation of chiral dihydrofurocoumarins was achieved under normal-phase mode on Chirobiotic T, TAG and R [15]. Considering that chiral 4C-substituted pyrrolidine-2-one derivatives 1–3 are neutral, separations were performed on four macrocyclic glycopeptide CSPs (V2 with vancomycin, R with ristocetin A, T with teicoplanin, and TAG with teicoplanin aglycone) in isocratic normal-phase mode. Effect of the type of chiral stationary phase (polysaccharide vs. macrocyclic glycopeptide with the same type of mobile phase ethanol/n-hexane) as well as the effect of the nature of analytes 1–3 on enantiomer retention, resolution and elution order was studied in this investigation.
Materials and Methods
Reagents and Standards
Hexane for HPLC (≥ 97.0%), and 1,3,5-tri-tert-butylbenzene were purchased from Sigma–Aldrich (Steinheim, Germany). Anhydrous ethanol (99.8%) was obtained from Fisher Scientific (Loughborough, UK). Racemic compounds and enantiomers were synthesized at the Latvian Institute of Organic Synthesis (Riga, Latvia).
Chromatographic System and Conditions
Experiments were performed on Waters Alliance (Waters Corporation, Torrance, CA, USA) LC system equipped with 2695 separation module with quaternary pump, degasser, autosampler, and column heater. Waters 2489 dual λ absorbance detector was used for the analysis. The output signal in LC system was monitored and processed using Waters Empower 2 software.
Separation was performed on immobilized polysaccharide-based columns {Chiralpak IC (here and further abbreviation IC) packed with cellulose tris (3,5-dichlorophenylcarbamate) and Chiralpak IH (IH) based on amylose tris [(S)-α-methylbenzylcarbamate]; purchased from Chiral Technologies Europe (Illkirch, France)}, and macrocyclic glycopeptide columns {Chirobiotic V2 (V2) with vancomycin as CS, Chirobiotic R (R) with ristocetin A, Chirobiotic T (T) with teicoplanin, and Chirobiotic TAG (TAG) with teicoplanin aglycone CS; purchased from Supelco (Darmstadt, Germany)}. All columns within this study are 250 × 4.6 mm I.D., particle size 5 μm.
Ethanol (EtOH) mixtures with hexane (HEX) were used as mobile phases. The proportion of each mobile phase component was always measured by volume. Equilibration time is defined as 60 min. In order to confirm results, a minimum of three replicate injections were carried. 1,3,5-Tri-tert-butylbenzene was used as column void time marker.
The chromatographic runs were performed at flow rate 1.0 mL/min, and a column temperature of 25 °C. Detection was accomplished via measurement of the UV absorption at 210 nm. The injection volume was 10 µL. All analytes have been dissolved in the mobile phase before injection and analytical sample concentration was 1 mg mL−1. The enantiomeric elution order on the CSPs was established by analyzing racemic mixture and individual R-enantiomer samples.
Results and Discussion
Enantioseparation of 4C-substituted pyrrolidin-2-one derivatives (1–3; Fig. 1), differing with both the substituent at position 4C (a–e), and the substituent at N (1–3) in pyrrolidine-2-one cycle, were tested in chromatographic systems consisting of ethanol/n-hexane mobile phases and commercially available immobilized CSPs, such as polysaccharide-based IC (tris (3,5-dichlorophenylcarbamate) as CS) and IH (amylose tris [(S)-α-methylbenzylcarbamate] as CS), macrocyclic glycopeptide-based V2 (vancomycin as CS), R (ristocetin A as CS), T (teicoplanin as CS), and TAG (teicoplanin aglycone as CS). Fixed retention factor value (k ~ 3 for the first eluted enantiomer of compounds 1a, 2a and 3a) was set by adjusting the concentration of EtOH in n-hexane for each experiment (Table 1). The experimental results are presented in Tables S1–S6 (Electronic Supplementary materials).
Polysaccharide-Based Chiral Stationary Phases
Chromatographic behavior of analytes 1–3 (Fig. 1) was studied on columns IC (Table S1) and IH (Table S2) with eluents, consisting of mixture of ethanol/n-hexane (Table 1).
4C-Substituted Pyrrolidin-2-Ones
Only three out of five enantiomeric pairs of pyrrolidine-2-ones 1 could be separated with Rs ≥ 2 on cellulose-based IC (mobile phase 25% EtOH/75% Hex; Table 1). Poor resolution was observed for 4-isopropyl-substituted 1e (Rs < 0.5), and for 4-(p-tolyl)-substituted 1b (Rs = 1.1). The latter is apparently associated with a stronger retention of the S-enantiomer 1b, as compared to the S-enantiomer of 4-phenyl-substituted 1a (Fig. 1). In all cases, S-enantiomers are eluted first on IC columns.
On methylbenzylcarbamate containing IH CSP, mixture of 70% EtOH in n-hexane was necessary to retain compound 1a with k ~ 3 (Table 1). This strong retention may have occurred due to strong π–π interactions between aromatic ring in the CSP and aromatic ring system in analytes 1a–d structure. However, comparing the poor enantioseparation of 4-phenyl-substituted 1a (Rs = 1.3) with the resolution of 4-isopropyl-substituted 1e (similar retention, Rs = 3.4), suggests, that enantioseparation of compounds 1 is more likely driven by intermolecular hydrogen bonds in combination with steric effects, rather than π–π- interactions alone. According to Fig. 1, among 4C-substituted pyrrolidine-2-ones 1, compound 1e shows the weakest retention on phenylcarbamate IC phase, whereas on (S)-methylbenzylcarbamate-based IH, R-enantiomer of 1e (k ~ 3.60) retains stronger than 4-phenyl-substituted 1a (k ~ 3.21), and retention of S-enantiomers of 1e (k ~ 2.93) and 1a (k ~ 2.97) differs only slightly.
Our previous experiments showed that compounds containing bulkier alkyl substituent in pyrrolidin-2-one cycle (4-isopropyl-substituted 1e resolved with Rs = 0.9 vs. 4-isobutylpyrrolidin-2-one with Rs = 2.9) improved enantioresolution [8]. Chromatographic behavior of the above mentioned compounds on IC and IH CSPs was studied, and poor enantioseparation of 4-isobutylpyrrolidin-2-one (Rs < 0.5) was observed on IH phase, while no resolution was achieved on IC phase (Fig. S1). It is possible that the bulky nature of the CS in IH and IC phases creates such steric environment that reduced the chiral recognition of 4-isobutylpyrrolidin-2-one.
Enantiomers of four out of five pyrrolidine-2-ones 1 could be separated (with Rs ≥ 2) on IH column (Table 1). Despite the fact that none of the previously studied CSPs [8, 9] were capable to baseline separate 4-isopropyl-substituted pyrrolidin-2-one 1e, the IH phase was able to separate enantiomers with Rs > 2.
By providing alternate selectivity for enantioresolution of various new 4C-substituted pyrrolidin-2-ones 1, due to its unique chiral recognition, IH CSP is a great addition for screening in HPLC method development.
4C-Substituted Ethyl 2-(2-Oxopyrrolidin-1-yl) Acetates
As shown in Fig. 1, good enantioseparation of 4-aryl-substituted acetates 2a—2d could be achieved on IC CSP. Poor resolution (Rs < 0.5) was observed only for enantiomers of 4-isopropyl-substituted 2e (Table S1). In all cases, S-enantiomers of the studied ethyl 2-(2-oxopyrrolidin-1-yl) acetates are eluted first on IC column.
Even though immobilized amylose-based IH phase was able to resolve 4-isopropyl-substituted 2e (Rs = 2.11; Table S2), the enantioresolution of compounds 2b and 2d was not achieved, possibly, due to the specific steric environment in the IH CS.
For this investigation, racemic 4-isobutyl-substituted acetate 2 was synthesized and its chromatographic behavior was compared with 4-isopropyl-substituted acetate 2e on IC and IH CSPs (Fig. S2). Increase in resolution of the analyte containing bulkier alkyl substituent in pyrrolidin-2-one cycle (vs. acetate 2e) was observed on both CSPs (IC, Rs = 3.01 vs. Rs = 0.91; IH, Rs = 2.95 vs. Rs = 2.11).
The chromatographic behavior of the various 4C-substituted acetate derivatives 2 is difficult to predict for polysaccharide-based CSPs. However, enantiomers of 4 out of 5 studied chiral analytes 2 could be separated on IC phase with Rs ≥ 2 (Table S1).
4C-Substituted 2-(2-Oxopyrrolidin-1-yl) Acetamides
Our previous study has shown that immobilized amylose-based phases with only electron-donating (CH3) or electron-withdrawing (Cl) substituents at positions 3 and 5 of phenylcarbamate significantly impair the resolution of chiral 2-(2-oxopyrrolidin-1-yl) acetamides 3 [9]. Thus, the separation ability of the immobilized IC phase (cellulose derivatized with 3,5-dichlorophenylcarbamate) of enantiomers 3a—3e was unclear. It was established that 45% EtOH/55% Hex mobile phase was necessary to retain 3a with k ~ 3 on IC phase (Table S1). Enantioresolution with Rs ≥ 2 was achieved for all acetamide derivatives 3 tested (Table 1). Very strong retention was observed for R-enantiomer 3d (Fig. 1; see also Fig. S3).
When determining enantiomeric purity, it can be considered an advantage, to be able to control the retention order for enantiomers in such way, that the enantiomer with the lowest concentration eluted first. It is known that the R-enantiomer of compound 3a was found to be a more pharmacologically active psycho-stimulating compound than the S-enantiomer. Moreover, the cognitive enhancing effect was only observed for R-enantiomer [3]. Therefore, IC CSP (due to the quicker elution of S-enantiomers in all experiments, Table 1) should be the primary candidate in determining the S-enantiomers as impurities.
On amylose-based IH phase (35% EtOH / 65% HEX; Table 1) 4-aryl-substituted 3a–d were resolved with Rs ~ 5 (Table S2). More problematic was the separation of 4-isopropyl-substituted 3e enantiomers (Rs < 0.5). In all cases R-enantiomer is eluted first on IH phase (Fig. 1).
In general, IC and IH columns can be considered suitable for enantioseparation of various 4C-substituted 2-(2-Oxopyrrolidin-1-yl) acetamides (see also Fig. S4).
Macrocyclic Glycopeptide-Based Chiral Stationary Phases
The use of macrocyclic glycopeptide phases V2 (vancomycin as CS; Table S3), R (ristocetin A as CS; Table S4), T (teicoplanin as CS; Table S5), and TAG (teicoplanin aglycone as CS; Table S6) was studied for the resolution of the enantiomers of compounds 1–3 (Fig. 2) using ethanol/n-hexane containing eluents (Table 1).
4C-Substituted Pyrrolidin-2-Ones
On macrocyclic glycopeptide-based CSP V2, pyrrolidin-2-ones 1a—1e are relatively weakly retained (20% EtOH in n-hexane is sufficient to retain 1a within k ~ 3; Table S3), without enantioresolution (Fig. 2). Stronger retention of 4-aryl-substituted compounds 1a–d could be achieved by employing other macrocyclic glycopeptide CSPs: R (40% EtOH), T (55% EtOH) and TAG (70% EtOH). On ristocetin CS resolution value for enantiomers of 4-aryl-substituted 1a–d fluctuates from 1.4 to 2.1 (Table S4), and only teicoplanin and teicoplanin aglycone CSs were able to resolve 1a–d enantiomers with Rs > 3 (Tables S5, S6). It can be seen (Table 1) that R-enantiomers eluted first.
Chromatographic behavior of 4-isopropyl- and 4-isobutylpyrrolidin-2-one on macrocyclic glycopeptide CSPs was compared (Fig. S5). Enantioresolution of compound 1e was observed only on T CSP (Rs = 1.22). At the same time, 4-isobutylpyrrolidin-2-one was resolved on T CSP with Rs = 2.90, and chiral recognition was observed also on TAG CSP (Rs = 1.80).
In general, macrocyclic glycopeptide-based phases T and TAG can be used for separation of enantiomers of pyrrolidin-2-ones 1 (Fig. 2).
4C-Substituted Ethyl 2-(2-Oxopyrrolidin-1-yl) Acetates
The chromatographic behavior of 4C-substituted ethyl 2-(2-oxopyrrolidin-1-yl) acetates 2 on macrocyclic glycopeptide CSPs was tested (Tables S3–S6). Mobile phase with 10% EtOH appeared to be sufficient in retaining 2a with k ~ 3 on V2 phase, 15% EtOH on R and T, while 20% EtOH was necessary on TAG (Table 1). Poor resolution (Rs < 0.5) was observed on vancomycin CS, and no chiral recognition was achieved on ristocetin phase (Fig. 2). Only enantiomers of compounds 2a and 2c could be baseline separated (Rs > 2; Table S5) on teicoplanin CS, whereas good enantioresolution (Rs > 4; Table S6) of chiral compounds 2a–d was achieved on teicoplanin aglycone phase (R-enantiomers eluted first).
None of the macrocyclic glycopeptide-based CSPs studied was able to resolve 4-isopropyl-substituted 2e (Table 1). Nevertheless, introducing bulkier alkyl substituent (4-isobutyl) slightly improved the enantiorecognition (Rs = 0.9) of ethyl 2-(2-oxopyrrolidin-1-yl) acetate 2 on TAG CSPs.
In general, TAG CSP can be used for separation of enantiomers of 4-substituted ethyl 2-(2-oxopyrrolidin-1-yl) acetates 2 (Table 1).
4C-Substituted 2-(2-Oxopyrrolidin-1-yl) Acetamides
According to Table 1 data mobile phase containing 55% EtOH was sufficient to retain 3a with k ~ 3 on V2, 60% EtOH on T, 65% EtOH on R and 70% EtOH on TAG phases. Despite stronger retention on the last two phases, the best chiral recognition ability of 4C-substituted 2-(2-oxopyrrolidin-1-yl) acetamide derivatives 3 was achieved on vancomycin CSP (S-enantiomers eluted first; Fig. 2). Resolution of additional chiral compounds 3 was also tested on macrocyclic glycopeptide-based CSPs, and V2 phase showed the best chiral recognition ability (Fig. S7).
In general, V2 CSP can be used for separation of enantiomers of 4-substituted ethyl 2-(2-oxopyrrolidin-1-yl) acetamide analogs 3 (Table 1).
Conclusions
As shown in this investigation, by employing chiral selector based on cellulose tris (3,5-dichlorophenylcarbamate), using ethanol/n-hexane containing eluents, 12 out of 15 enantiomeric pairs studied were separated with Rs ≥ 2. Only two of the previously studied eleven polysaccharide-based phases showed such result. In addition, a specific enantiomer elution order, where the S-enantiomer is always eluted first, was observed on the IC phase. It was established that, amylose tris [(S)-α-methylbenzylcarbamate] chiral selector shows unique chiral recognition, in comparison with the studied phenylcarbamate-based phases. In general terms, both studied polysaccharide-based CSPs seem very promising for the development of HPLC methods for enantioresolution of various new 4C-substituted pyrrolidin-2-one derivatives.
The polysaccharide CSPs are derivatized with moieties that are largely nonpolar, with only the carbamate linkages possessing polar character, while macrocyclic glycopeptides have an abundance of polar groups. However, results showed that the concentration of ethanol in mobile phase mainly depends on nature of the compounds. The type of the analytes played an important role in the chiral discrimination, especially on macrocyclic glycopeptide-bases CSPs. Although, normal-phase elution is typical for polysaccharide-based CSPs, whereas reversed and polar ionic modes are most commonly used on macrocyclic glycopeptide CSPs. Enantioseparation of 4C-substituted pyrrolidin-2-one derivatives under normal-phase elution was achieved on both types of studied CSPs. It was established that 4-aryl-pyrrolidin-2-ones could be resolved with Rs ≥ 2 on teicoplanin or teicoplanin aglycone chiral selectors, teicoplanin aglycone phase was also able to separate enantiomers of 4-aryl-substituted ethyl 2-(2-oxopyrrolidin-1-yl) acetates, whereas 4-aryl-substituted ethyl 2-(2-oxopyrrolidin-1-yl) acetamides could only be resolved on vancomycin phase.
References
Malykh AG, Sadaie MR (2010) Piracetam and piracetam-like drugs. Drugs 70:287–312
Veinberg G, Vavers E, Orlova N et al (2015) Stereochemistry of phenylpiracetam and its methyl derivative: improvement of the pharmacological profile. Chem Heterocycl Compd 51:601–606
Zvejniece L, Svalbe B, Veinberg G et al (2011) Investigation into stereoselective pharmacological activity of phenylpiracetam. Basic Clin Pharmacol Toxicol 109:407–412
Kažoka H, Koliškina O, Veinberg G, Vorona M (2013) Separation of piracetam derivatives on polysaccharide-based chiral stationary phases. J Chromatogr A 1281:160–165
Lin Z, Tai HC, Zhu G et al (2021) Evaluation of a polysaccharide-based chiral reversed-phase liquid chromatography screen strategy in pharmaceutical analysis. J Chromatogr A 1645:462085
Shen J, Okamoto Y (2016) Efficient separation of enantiopmers using stereoregular chiral polymers. Chem Rev 116:1094–1138
Chankvetadze B (2020) Recent trends in preparation, investigation and application of polysaccharide-based chiral stationary phases for separation of enantiomers in high-performance liquid chromatography. Trends Anal Chem 122:115709
Upmanis T, Kažoka H, Orlova N, Vorona M (2020) Separation of 4C-substituted pyrrololidine-2-one derivatives on polysaccharide-based coated chiral stationary phases. Chromatographia 83:331–340
Kažoka H, Turovska B, Upmanis T, Orlova N, Vorona M (2021) Separation of 4C-substituted pyrrololidine-2-one derivatives on amylose-based chiral stationary phases. Chromatographia 84:635–675
Zhang T, Nguyen D, Franco P et al (2006) Cellulose 3,5-dimethylcarbamate immobilized on silica A new chiral stationary phase for the analysis of enantiomers. Anal Chim Acta 557:221–228
Zhang T, Nguyen D, Franco P et al (2008) Enantiomer resolution screening using multiple immobilized polysaccharide-based chiral stationary phases. J Chromatogr A 1191:214–222
Rosetti A, Villani C, Pierini M, Cirilli R (2021) Comparison of coated and immobilized chiral stationary phases based on amylosetris-[(S)-α-methylbenzylcarbamate] for the HPLC enantiomer separation of α-lipoic acid and its reduced form. Molecules 26:1747
Beesley TE, Lee JT (2007) In: Subramania G (ed) Chiral separation techniques, 3rd edn. Wiley-VCH, Weinheim
Xiao TL, Rozhkov RV, Larock RC, Armstrong DW (2003) Separation of the enantiomers of substituted dihydrofurocoumarins by HPLC using macrocyclic glycopeptide chiral stationary phases. Anal Bioanal Chem 377:639–654
Berkecz R, Tanacs D, Peter A, Ilisz I (2021) Enanioselective liquid chromatographic separations using macrocyclic glycopeptide-based chiral selectors. Molecules 26:3380
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kažoka, H., Turovska, B., Upmanis, T. et al. Enantioseparation of 4C-Substituted Pyrrolidin-2-One Derivatives on Polysaccharide and Macrocyclic Glycopeptide Chiral Stationary Phases. Chromatographia 85, 489–495 (2022). https://doi.org/10.1007/s10337-022-04145-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-022-04145-z